Thermo Fisher Scientific Short-term debt and current portion of long-term debt decreased by 12.5% to $3.09B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.6%, from $2.82B to $3.09B. Over 5 years (FY 2020 to FY 2025), Short-term debt and current portion of long-term debt shows an upward trend with a 6.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Lower levels reduce immediate liquidity pressure, while high levels may signal a need for refinancing or significant cash outflows.
The portion of total debt obligations, including bank loans and notes, that is due for repayment within the next twelve...
A key indicator of short-term financial health compared to peers with similar capital structures.
other_debt_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.00M | $19.00M | $2.54B | $1.87B | $1.01B | $1.01B | $5.58B | $6.12B | $4.81B | $4.80B | $3.61B | $4.45B | $5.12B | $4.12B | $2.21B | $2.82B | $2.21B | $3.82B | $3.53B | $3.09B |
| QoQ Change | — | +375.0% | >999% | -26.4% | -45.9% | +0.0% | +452.4% | +9.7% | -21.4% | -0.4% | -24.7% | +23.3% | +15.1% | -19.6% | -46.2% | +27.3% | -21.5% | +72.7% | -7.6% | -12.5% |
| YoY Change | — | — | — | — | >999% | >999% | +119.9% | +228.1% | +376.6% | +374.8% | -35.3% | -27.3% | +6.4% | -14.2% | -38.7% | -36.7% | -56.8% | -7.1% | +59.6% | +9.6% |